Sue Noy was joined to HEROES project on September 2018. Sue is a member of the LonDownS Consortium mouse work stream and is involved in phenotyping novel mouse models of DS and AD-DS neurodegeneration using a range of immunohistochemical techniques. Sue read Zoology and Human Physiology at the University of London and completed a Ph.D in invertebrate neuroscience studying the distribution and cellular localisation of novel neuropeptides. As a Postdoc, Sue joined the Neuroscience group at SmithKline Beecham / GSK phenotyping models of Alzheimer's disease Neurodegeneration primarily in the rat but later in the first of the genetically modified PS1 mice. From GSK, Sue then joined the Drug Safety Research and Development team at Pfizer UK, de-risking candidate drug targets for a wide range of therapeutic areas including Neurodegeneration and Neuropathic pain. HEROES team wish Sue lots of success!